Clinical Trial Update: Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating treatment for children and adolescents with refractory or relapsed acute myeloid leukemia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Dutch Childhood Oncology Group | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED